InsiderClue
Stocks · Health care · In Vitro & In Vivo Diagnostic Substances

QuidelOrtho Corp

QDEL Clue Score37
United States Fiscal year ends January CIK 0001906324
$13.42 +8.14% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $13.42 −90.12% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2021Revenue1,661.7Operating income1,060.3Net income810.3EPS, diluted18.60Fiscal year 2022Revenue1,698.6 +2.2%Operating income906.0Net income704.2 −13.1%EPS, diluted16.43 −11.7%Fiscal year 2023Revenue3,266.0 +92.3%Operating income843.7Net income548.7 −22.1%EPS, diluted9.56 −41.8%Fiscal year 2023Revenue2,997.8 −8.2%Operating income139.1Net income−10.1 −101.8%EPS, diluted−0.15 −101.6%Fiscal year 2024Revenue2,782.9 −7.2%Operating income−1,960.9Net income−2,052.0EPS, diluted−30.54Fiscal year 2025Revenue2,730.2 −1.9%Operating income−919.2Net income−1,131.8EPS, diluted−16.69
FY2021FY2022FY2023FY2023FY2024FY2025
Revenue 1,661.7 1,698.6 3,266.0 2,997.8 2,782.9 2,730.2
Growth +2.2% +92.3% −8.2% −7.2% −1.9%
Operating income 1,060.3 906.0 843.7 139.1 −1,960.9 −919.2
Net income 810.3 704.2 548.7 −10.1 −2,052.0 −1,131.8
Growth −13.1% −22.1% −101.8%
EPS, diluted 18.60 16.43 9.56 −0.15 −30.54 −16.69
Growth −11.7% −41.8% −101.6%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2021Operating margin63.8%Net margin48.8%Free cash flow margin34.0%Fiscal year 2022Operating margin53.3%Net margin41.5%Free cash flow margin30.2%Fiscal year 2023Operating margin25.8%Net margin16.8%Free cash flow margin22.8%Fiscal year 2023Operating margin4.6%Net margin−0.3%Free cash flow margin2.4%Fiscal year 2024Operating margin−70.5%Net margin−73.7%Free cash flow margin−4.0%Fiscal year 2025Operating margin−33.7%Net margin−41.5%Free cash flow margin−3.0%
FY2021FY2022FY2023FY2023FY2024FY2025
Operating margin 63.8% 53.3% 25.8% 4.6% −70.5% −33.7%
Net margin 48.8% 41.5% 16.8% −0.3% −73.7% −41.5%
Free cash flow margin 34.0% 30.2% 22.8% 2.4% −4.0% −3.0%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2021Operating cash flow629.7Capital expenditure−64.9Free cash flow564.8Buybacks−43.7Fiscal year 2022Operating cash flow805.9Capital expenditure−292.8Free cash flow513.1 −9.2%Buybacks−103.5Fiscal year 2023Operating cash flow885.3Capital expenditure−140.9Free cash flow744.4 +45.1%Buybacks−74.3Fiscal year 2023Operating cash flow280.2Capital expenditure−209.3Free cash flow70.9 −90.5%Buybacks−7.2Fiscal year 2024Operating cash flow83.0Capital expenditure−195.1Free cash flow−112.1 −258.1%Buybacks0.0Fiscal year 2025Operating cash flow105.2Capital expenditure−188.2Free cash flow−83.0Buybacks0.0
FY2021FY2022FY2023FY2023FY2024FY2025
Operating cash flow 629.7 805.9 885.3 280.2 83.0 105.2
Capital expenditure −64.9 −292.8 −140.9 −209.3 −195.1 −188.2
Free cash flow 564.8 513.1 744.4 70.9 −112.1 −83.0
Growth −9.2% +45.1% −90.5% −258.1%
Buybacks −43.7 −103.5 −74.3 −7.2 0.0 0.0

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2021Cash489.9Shareholders’ equity1,332.7Fiscal year 2022Cash802.8Total debt0.3Net cash (debt)802.5Shareholders’ equity1,929.4Debt to equity0.00Fiscal year 2023Cash292.9Total debt2,856.4Net cash (debt)−2,563.5Shareholders’ equity4,934.6Debt to equity0.58Fiscal year 2023Cash118.9Total debt2,562.4Net cash (debt)−2,443.5Shareholders’ equity5,005.9Debt to equity0.51Fiscal year 2024Cash98.3Total debt2,830.4Net cash (debt)−2,732.1Shareholders’ equity2,984.5Debt to equity0.95Fiscal year 2025Cash169.8Total debt2,876.0Net cash (debt)−2,706.2Shareholders’ equity1,920.5Debt to equity1.50
FY2021FY2022FY2023FY2023FY2024FY2025
Cash 489.9 802.8 292.9 118.9 98.3 169.8
Total debt n/a 0.3 2,856.4 2,562.4 2,830.4 2,876.0
Net cash (debt) n/a 802.5 −2,563.5 −2,443.5 −2,732.1 −2,706.2
Shareholders’ equity 1,332.7 1,929.4 4,934.6 5,005.9 2,984.5 1,920.5
Debt to equity n/a 0.00 0.58 0.51 0.95 1.50

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2021 3 Jan 2021 FY2022 2 Jan 2022 FY2023 1 Jan 2023 FY2023 31 Dec 2023 FY2024 29 Dec 2024 FY2025 28 Dec 2025
Revenue and profit
1,661.7 1,698.6 3,266.0 2,997.8 2,782.9 2,730.2
Growth +2.2% +92.3% −8.2% −7.2% −1.9%
84.3 95.7 187.9 245.0 218.7 186.2
180.7 239.6 621.0 763.2 766.8 746.3
1,060.3 906.0 843.7 139.1 −1,960.9 −919.2
Growth −14.6% −6.9% −83.5% −1,509.7%
1,040.3 900.3 735.9 −29.1 −2,131.5 −1,107.7
230.0 196.1 187.2 −19.0 −79.5 24.1
810.3 704.2 548.7 −10.1 −2,052.0 −1,131.8
Growth −13.1% −22.1% −101.8%
Per share
19.24 16.74 9.66 −0.15 −30.54 −16.69
18.60 16.43 9.56 −0.15 −30.54 −16.69
Growth −11.7% −41.8% −101.6%
42.1 42.1 56.8 66.8 67.2 67.8
43.6 42.9 57.4 66.8 67.2 67.8
Growth −1.6% +33.8% +16.4% +0.6% +0.9%

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 10.4% a year over five years.
  • The diluted share count rose 55.5% in five years, which is dilution.
  • Operating margin is down 97.5 points on five years ago, at -33.7%.
  • A net loss in 3 of 6 years on file.